Literature DB >> 11172590

Expression and function of interleukin-8 in human hepatocellular carcinoma.

J Akiba1, H Yano, S Ogasawara, K Higaki, M Kojiro.   

Abstract

Expression and functions of interleukin (IL)-8, a pro-inflammatory cytokine with angiogenesis action, was examined in 23 surgically resected hepatocellular carcinoma (HCC) specimens and 7 HCC cell lines. In all HCC tissues, IL-8 expression was confirmed with reverse-transcription polymerase chain reaction method and enzyme-linked immunosorbent assay, and immunohistochemistry showed HCC cells were the major producer of IL-8 in the tissues. Microvessel density was measured by the double immunohistochemical staining of muscular vessels in HCC tissues, but the density was not related to the level of IL-8 in the HCC tissues. On the other hand, in the co-culture of human umbilical vein endothelial cells (HUVEC) and a HCC cell line (KIM-1), IL-8 produced by KIM-1 significantly accelerated the proliferation of HUVEC. In addition, cases with a high IL-8 level in cancerous tissue had a significantly higher frequency of portal vein invasion, venous invasion and bile duct invasion (p<0.05). In the cultures of 7 HCC cell lines IL-8 secretion into culture medium increased with the treatment of IL-1beta or tumor necrosis factor-alpha. This showed IL-8 expression is regulated by inflammatory cytokines. IL-8 produced by HCC is an angiogenesis factor of HCC, but it could have a much more important role in the invasion and metastasis of HCC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172590     DOI: 10.3892/ijo.18.2.257

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  39 in total

Review 1.  Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma.

Authors:  Shinji Tanaka; Shigeki Arii
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

2.  3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways.

Authors:  Peter DelNero; Maureen Lane; Scott S Verbridge; Brian Kwee; Pouneh Kermani; Barbara Hempstead; Abraham Stroock; Claudia Fischbach
Journal:  Biomaterials       Date:  2015-04-13       Impact factor: 12.479

3.  Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells.

Authors:  Liang Zhang; Huanyu Wang; Tianshu Yang; Zhifeng Su; Dan Fang; Yafeng Wang; Jiazhu Fang; Xinwei Hou; Yingying Le; Keqiang Chen; Ji Ming Wang; Shao Bo Su; Qing Lin; Qi Zhou
Journal:  Oncoimmunology       Date:  2015-08-24       Impact factor: 8.110

Review 4.  Immunological landscape and immunotherapy of hepatocellular carcinoma.

Authors:  Jesús Prieto; Ignacio Melero; Bruno Sangro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-20       Impact factor: 46.802

Review 5.  Prohibitin 1 in liver injury and cancer.

Authors:  Lucía Barbier-Torres; Shelly C Lu
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-20

6.  Association of interleukin-8 gene polymorphisms with the risk of hepatocellular carcinoma.

Authors:  Jun-li Wang; Le-gen Nong; Ye-sheng Wei; Yu-jin Tang; Jian-chu Wang; Chun-fang Wang
Journal:  Mol Biol Rep       Date:  2014-01-01       Impact factor: 2.316

Review 7.  Serum tumor markers for detection of hepatocellular carcinoma.

Authors:  Lin Zhou; Jia Liu; Feng Luo
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

8.  The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma.

Authors:  Ning Zhang; Lu Wang; Ying Liang; Yi-Ming Zhao; Qiong Xue; Wei-Zhong Wu; Hui-Chuan Sun; Jia Fan; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-28       Impact factor: 4.553

9.  Interleukin-8 producing hepatocellular carcinoma with pyrexia.

Authors:  Norifumi Harimoto; Ken Shirabe; Tomoyuki Abe; Kiyoshi Kajiyama; Takashi Nagaie; Tomonobu Gion; Yousuke Kuroda; Yoshihiko Maehara
Journal:  HPB Surg       Date:  2009-08-23

10.  Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4.

Authors:  Abdel-Rahman N Zekri; Hanaa M Alam El-Din; Abeer A Bahnassy; Naglaa A Zayed; Waleed S Mohamed; Suzan H El-Masry; Sayed K Gouda; Gamal Esmat
Journal:  Comp Hepatol       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.